Product Description
| Download Documents | |
| SDS | Product Sheet |
| COA-050721 | |
Alprenolol is an antagonist for ß1 and ß2 adrenergic receptors. Alprenolol agarose affinity chromatography was first introduced by Lefkowitz R. J. in 1979 (References 1 and 2) for the purification of erythrocyte ß-adrenergic receptor based on ligand-receptor interactions. It is now routinely used for the purification of functionally active ß1 and ß2-adrenergic receptor. CellMosaic’s SepSphere™ Alprenolol Agarose is composed of Agarose 4B Beads linked to alprenolol via a thiol ether linkage.
Chemical Information
Alprenolol immobilized on agarose 4B beads through thiol ether linkage.
Specification
-
Ligand: alprenolol
-
Physical appearance: suspension in 0.02% NaN3 solution.
-
Immobilization method: immobilized through the reaction of the double bond of alprenolol and S-alkyl-thiosulfate agarose.
-
Storage temp.: 2- 8 °C
-
Ligand concentration: 1 ~ 3 uMole per mL of settled beads by thiol assay
-
Matrix: agarose 4B (source: GE Life Science).
-
Spacer: 12 atoms
-
Particle size: 45-165 um
References
- Shorr, R., G.; Lefkowitz, R. J.; Caron, M. G. Purification of the ß-adrenergic receptor. J. Bio. Chem. 1981, 256(11), 5820-5826;
- Caron, M. G.; Srinivasan, Y.; Pitha, J.; Kociolek, K.; Lefkowitz, R. J. Affinity chromatoraphy of the ß-adrenergic receptor J. Bio. Chem. 1979, 254(8), 2923-2927.
Citations from Customer Who Used Our Product:
Salom, D.; Padayatti, P. S.; Palczewski, K. Crystallization of G protein-coupled receptors Methods Cell Biology 2013, 117, 451-468. DOI: 10.1016/B978-0-12-408143-7.00024-4
Cheong, H. I.; Asosingh, K.; Stephens, O. R.; Queisser, K. A.; Xu, W.; Willard, B.; Hu, B.; Dermawan, J. K. T.; Stark, G. R.; Naga Prasad, S. V.; Erzurum, S. C. Hypoxia sensing through β-adrenergic receptors JCI Insight 2016, 1(21), e90240. DOI: 10.1172/jci.insight.90240
Frequently Asked Questions:
If you can’t find the answer you’re looking for or need information on general topics, please visit the main Frequently Asked Questions (FAQs) section.